Overview
Top Medical Research Studies
Our findings indicated that MS patients generally had elevated levels of homocysteine compared to control groups, suggesting a potential risk factor in their condition. On the other hand, we noted that individuals with MS, particularly those experiencing relapses, showed lower levels of vitamin B12. This points toward a potential connection between low vitamin B12 and the exacerbation of MS symptoms. However, it’s worth noting that we didn't find significant differences in folate levels among the groups, implying that folate may not play the same role in MS as Hcy and VB12.
In summary, while the study highlights concerns regarding elevated homocysteine and decreased vitamin B12 levels in MS patients, it also suggests that vitamin B12 may correlate with the frequency of relapses, offering some insight into how dietary factors could influence MS management. Therefore, this research underscores the importance of monitoring vitamin B12 levels in MS patients as part of a comprehensive treatment strategy.
Blood samples were collected before and after the treatment to measure key indicators of inflammation and immune response, specifically interleukin (IL)-10 and osteopontin (OPN) levels. We also looked at the expression levels of various microRNAs linked to inflammation. The findings revealed that while IFN-β alone did not alter IL-10 levels or microRNA expressions of miR-106a and miR-299a, it did significantly lower OPN concentration and increased the levels of let-7c and miR-146a.
In contrast, the group receiving the combination of IFN-β and B12 showed a marked decrease in IL-10 and OPN levels, alongside a drop in miR-106a expression, while let-7c and miR-146a levels increased substantially. However, it is notable that there was no correlation found between IL-10, OPN, and the relevant microRNAs in either treatment group.
Our study suggests that while vitamin B12 might play a role in the overall treatment process, its effects are intertwined with those of IFN-β, and the specific benefit of B12 alone remains unclear.
The results were encouraging. We observed significant improvements in visual acuity and foveal sensitivity threshold after treatment. For example, visual acuity showed a notable enhancement (p = 0.002), while foveal sensitivity also improved substantially (p = 0.006). Additionally, correlations between age and visual outcomes indicated that younger patients tend to benefit more in terms of visual function recovery.
Importantly, our findings suggest that high-dose vitamin B12, in conjunction with other B vitamins, can positively affect visual function in MS-related visual disability. However, it's essential to note that while vitamin B12 is part of this promising combination therapy, its isolated effects warrant further investigation.
Most Useful Reviews
Medical Researches
- All Researches
The results were encouraging. We observed significant improvements in visual acuity and foveal sensitivity threshold after treatment. For example, visual acuity showed a notable enhancement (p = 0.002), while foveal sensitivity also improved substantially (p = 0.006). Additionally, correlations between age and visual outcomes indicated that younger patients tend to benefit more in terms of visual function recovery.
Importantly, our findings suggest that high-dose vitamin B12, in conjunction with other B vitamins, can positively affect visual function in MS-related visual disability. However, it's essential to note that while vitamin B12 is part of this promising combination therapy, its isolated effects warrant further investigation.
Treatment with the vitamin B complex showed promising results by easing the clinical symptoms of EAE and shortening the duration of the disease. We observed significant changes: in rats treated with the vitamin B complex, nerve and muscle nuclear density decreased at the onset of EAE but increased by the end of the disease. Additionally, there were fewer lymphoid follicles and smaller granulomas in the lymph nodes of these treated rats.
Furthermore, we analyzed the gut microbiota using advanced sequencing techniques, and our findings suggest that vitamin B complex treatment helps maintain a healthy balance in gut bacteria. Overall, we found that vitamin B treatment not only supported recovery in EAE but also positively influenced changes in the affected nerves and muscles.
As the first case progressed, she faced severe deterioration, requiring intensive care after experiencing respiratory failure. Remarkably, following cobalamin treatment, she demonstrated significant improvements. This suggests that vitamin B12 may have a protective effect against disease progression, especially in those with neurological symptoms not typically associated with cobalamin deficiency.
Both siblings now lead active lives and have healthy children, which paints a hopeful picture. This study highlights the need for health professionals to consider cobalamin-related conditions when diagnosing demyelinating diseases. Moreover, it underscores the importance of careful diagnostic procedures and treatment approaches, even in the absence of classic signs of deficiency.
Blood samples were collected before and after the treatment to measure key indicators of inflammation and immune response, specifically interleukin (IL)-10 and osteopontin (OPN) levels. We also looked at the expression levels of various microRNAs linked to inflammation. The findings revealed that while IFN-β alone did not alter IL-10 levels or microRNA expressions of miR-106a and miR-299a, it did significantly lower OPN concentration and increased the levels of let-7c and miR-146a.
In contrast, the group receiving the combination of IFN-β and B12 showed a marked decrease in IL-10 and OPN levels, alongside a drop in miR-106a expression, while let-7c and miR-146a levels increased substantially. However, it is notable that there was no correlation found between IL-10, OPN, and the relevant microRNAs in either treatment group.
Our study suggests that while vitamin B12 might play a role in the overall treatment process, its effects are intertwined with those of IFN-β, and the specific benefit of B12 alone remains unclear.
Our findings showed that both vitamin B12 and estradiol benzoate appear to provide benefits for memory retrieval by activating certain proteins in the hippocampus, such as AKT, BDNF, and CREB. These proteins are known for their role in brain health and memory functions.
We found that the combination therapy was particularly effective, suggesting that using both substances together could offer a promising approach to tackling memory issues linked with MS. It’s exciting to see how these treatments might help improve cognitive impairment arising from this challenging condition.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, specifically the brain and spinal cord. In MS, the immune system mistakenly attacks the protective covering of nerve fibers known as myelin, leading to inflammation and damage. This disruption in communication between the brain and different parts of the body can result in a wide range of symptoms, including fatigue, difficulty walking, numbness, and problems with vision. The severity and types of symptoms can vary significantly from person to person, as well as over the course of the disease, which may manifest in cycles of exacerbations and remissions.
There are several forms of MS, including relapsing-remitting MS (the most common type), primary progressive MS, and secondary progressive MS. While the exact cause of MS is still not fully understood, factors such as genetic predisposition and environmental triggers are believed to play a role. Currently, there is no cure for MS, but treatment options exist that can help manage symptoms, reduce the frequency of flare-ups, and slow the progress of the disease. If you or someone you know is experiencing symptoms suggestive of MS, it is essential to consult a healthcare professional for an accurate diagnosis and tailored management plan.
Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a crucial role in several vital functions in the human body. It is essential for red blood cell formation, neurological function, and DNA synthesis. Naturally occurring in animal products, the vitamin can be found in high concentrations in meat, fish, eggs, and dairy, making it particularly important for those following a vegetarian or vegan diet, as plant-based sources of B12 are limited and often require supplementation.
A deficiency in vitamin B12 can lead to serious health issues, including anemia, fatigue, memory problems, and nerve damage. Due to its significance, it's crucial for individuals, particularly those at risk of deficiency, to ensure adequate intake through diet or supplementation. For most adults, the recommended daily allowance (RDA) is around 2.4 micrograms, though pregnant or breastfeeding women may require higher amounts. If you're considering B12 supplements, it's advisable to consult with a healthcare provider to determine the best option for your specific needs and health status.
This supplement, particularly vitamin B12, has garnered attention in the context of Multiple Sclerosis (MS) and is supported by various scientific studies. One study indicated that a combination of interferon-beta and vitamin B12 led to significant changes in inflammatory markers such as IL-10 and osteopontin (OPN) in MS patients, suggesting potential benefits when used alongside traditional MS therapies [1]. Furthermore, research on a vitamin B complex revealed promising results in alleviating clinical symptoms and enhancing neural recovery in rats with experimental autoimmune encephalomyelitis, which serves as a model for MS [2].
Moreover, high doses of B vitamins, including B12, have shown to improve visual function in MS patients suffering from optic neuritis, indicating that these vitamins can have a meaningful impact on specific MS-related disabilities [4]. Additionally, findings linking low vitamin B12 levels to increased relapse rates in MS patients point to its potential relevance in disease management [5]. While these studies collectively highlight the possible efficacy of vitamin B12 and its counterparts in treating aspects of MS, further research is warranted to establish the exact mechanisms and benefits of vitamin B12 on its own.
Based on user reviews, many individuals have reported significant improvements in their symptoms related to a variety of health issues following B12 supplementation. Users noted that vitamin B12, particularly in its active forms like methylcobalamin, has played a critical role in alleviating pain, enhancing energy levels, and helping to prevent conditions such as pernicious anemia and heart disease (Read Review). Several users highlighted its effectiveness in treating nervous system disorders and noted a reduction in symptoms related to neuropathy, fatigue, and even depression, indicating its broader impact on overall health (Read Review).
Many reviewers specifically mentioned the importance of vitamin B12 for the elderly and vegetarians, who may be at higher risk of deficiency. The supplement has been credited with supporting immune function and improving digestion, as well as showing promise in reducing the progression of chronic conditions such as atherosclerosis and amyotrophic lateral sclerosis (Read Review). However, it's crucial to note that while these improvements are encouraging, individual results can vary significantly.
Users have shared intriguing insights on the combination of B12 supplements with other nutritional aids to manage Multiple Sclerosis (MS). Many reports highlight not only the effectiveness of B12, particularly in its active forms like methylcobalamin, in managing symptoms associated with MS but also suggest that it can work synergistically with other vitamins and minerals to enhance overall benefits. Specifically, methylcobalamin has been noted to support the nervous system effectively, which is vital for individuals battling nerve-related complications from MS (Read Review).
Additionally, users emphasize the importance of integrated approaches that combine B12 with proper dietary management and other supplements to address fatigue and improve energy levels, which are common challenges for those with Multiple Sclerosis. Some have reported significant relief from symptoms when fueling the body with a holistic mix—highlighting the potential for B12 to play a pivotal role in a broader supplementation strategy aimed at managing MS symptoms (Read Review). However, individual results can vary, and users are advised to consult healthcare professionals when considering combining supplements.
Users report that vitamin B12 plays a significant role in treating various conditions, including Multiple Sclerosis. One user emphasizes that a deficiency in B12 leads to serious neurological issues, stressing that high doses are crucial in reducing the progression of diseases like atherosclerosis and potentially aiding in managing Multiple Sclerosis symptoms (Read Review). Another user mentions that Methylcobalamin, the active form of B12, is particularly beneficial for the nervous system and may aid in alleviating symptoms of neurological disorders (Read Review).
Furthermore, some reviews highlight the importance of vitamin B12 in preventing various diseases, stating it alleviates pain and prevents conditions such as pernicious anemia and depression, which can be relevant for Multiple Sclerosis patients (Read Review). Though specific dosages are not detailed in the user reviews provided, the overall sentiment suggests that higher doses of B12, especially in its active forms, could be beneficial for individuals managing the effects of Multiple Sclerosis.
Blood samples were collected before and after the treatment to measure key indicators of inflammation and immune response, specifically interleukin (IL)-10 and osteopontin (OPN) levels. We also looked at the expression levels of various microRNAs linked to inflammation. The findings revealed that while IFN-β alone did not alter IL-10 levels or microRNA expressions of miR-106a and miR-299a, it did significantly lower OPN concentration and increased the levels of let-7c and miR-146a.
In contrast, the group receiving the combination of IFN-β and B12 showed a marked decrease in IL-10 and OPN levels, alongside a drop in miR-106a expression, while let-7c and miR-146a levels increased substantially. However, it is notable that there was no correlation found between IL-10, OPN, and the relevant microRNAs in either treatment group.
Our study suggests that while vitamin B12 might play a role in the overall treatment process, its effects are intertwined with those of IFN-β, and the specific benefit of B12 alone remains unclear.
Treatment with the vitamin B complex showed promising results by easing the clinical symptoms of EAE and shortening the duration of the disease. We observed significant changes: in rats treated with the vitamin B complex, nerve and muscle nuclear density decreased at the onset of EAE but increased by the end of the disease. Additionally, there were fewer lymphoid follicles and smaller granulomas in the lymph nodes of these treated rats.
Furthermore, we analyzed the gut microbiota using advanced sequencing techniques, and our findings suggest that vitamin B complex treatment helps maintain a healthy balance in gut bacteria. Overall, we found that vitamin B treatment not only supported recovery in EAE but also positively influenced changes in the affected nerves and muscles.
The results were encouraging. We observed significant improvements in visual acuity and foveal sensitivity threshold after treatment. For example, visual acuity showed a notable enhancement (p = 0.002), while foveal sensitivity also improved substantially (p = 0.006). Additionally, correlations between age and visual outcomes indicated that younger patients tend to benefit more in terms of visual function recovery.
Importantly, our findings suggest that high-dose vitamin B12, in conjunction with other B vitamins, can positively affect visual function in MS-related visual disability. However, it's essential to note that while vitamin B12 is part of this promising combination therapy, its isolated effects warrant further investigation.
Our findings indicated that MS patients generally had elevated levels of homocysteine compared to control groups, suggesting a potential risk factor in their condition. On the other hand, we noted that individuals with MS, particularly those experiencing relapses, showed lower levels of vitamin B12. This points toward a potential connection between low vitamin B12 and the exacerbation of MS symptoms. However, it’s worth noting that we didn't find significant differences in folate levels among the groups, implying that folate may not play the same role in MS as Hcy and VB12.
In summary, while the study highlights concerns regarding elevated homocysteine and decreased vitamin B12 levels in MS patients, it also suggests that vitamin B12 may correlate with the frequency of relapses, offering some insight into how dietary factors could influence MS management. Therefore, this research underscores the importance of monitoring vitamin B12 levels in MS patients as part of a comprehensive treatment strategy.
References
- Hesamian MS, Shaygannejad V, Golabi M, Mirmosayyeb O, Andalib A, et al. The Role of Cobalamin on Interleukin 10, Osteopontin, and Related MicroRNAs in Multiple Sclerosis. Iran J Allergy Asthma Immunol. 2022;21:332. doi:10.18502/ijaai.v21i3.9806
- Mandić M, Mitić K, Nedeljković P, Perić M, Božić B, et al. Vitamin B Complex and Experimental Autoimmune Encephalomyelitis -Attenuation of the Clinical Signs and Gut Microbiota Dysbiosis. Nutrients. 2022;14. doi:10.3390/nu14061273
- Taherian N, Vaezi G, Neamati A, Etemad L, Hojjati V, et al. Vitamin B12 and estradiol benzoate improve memory retrieval through activation of the hippocampal AKT, BDNF, and CREB proteins in a rat model of multiple sclerosis. Iran J Basic Med Sci. 2021;24:256. doi:10.22038/IJBMS.2021.51469.11681
- Mallone F, Lucchino L, Franzone F, Marenco M, Carlesimo SC, et al. High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study. Drug Discov Ther. 2020;14:122. doi:10.5582/ddt.2020.03031
- Pan L, Yin Y, Chen J, Ma Z, Chen Y, et al. Homocysteine, vitamin B12, and folate levels in patients with multiple sclerosis in Chinese population: A case-control study and meta-analysis. Mult Scler Relat Disord. 2019;36:101395. doi:10.1016/j.msard.2019.101395
- Motte J, Kneiphof J, Straßburger-Krogias K, Pitarokoili K, Fisse AL, et al. Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases. Ther Adv Neurol Disord. 2019;12:1756286419872115. doi:10.1177/1756286419872115
